Grey matter and cognitive patterns in cognitive impaired subjects using CSF biomarker cut-offs

dc.contributor.authorMiralbell Blanch, Júlia
dc.contributor.authorSpulber, Gabriela
dc.contributor.authorHooshmand, Babak
dc.contributor.authorBesga, Ariadna
dc.contributor.authorMataró Serrat, Maria
dc.contributor.authorCedazo-Mínguez, Ángel
dc.contributor.authorKivipelto, Miia
dc.contributor.authorWahlund, Lars-Olof
dc.date.accessioned2026-01-26T17:32:38Z
dc.date.available2026-01-26T17:32:38Z
dc.date.issued2012
dc.date.updated2026-01-26T17:32:38Z
dc.description.abstractThe aim of this study was to investigate brain tissue volumes, grey matter (GM) distribution, and cognitive performance for cognitively impaired subjects using cerebrospinal fluid (CSF) biomarker cut-offs as grouping criteria. 41 subjects attending the Memory Clinic, Karolinska University Hospital, Huddinge, Sweden, were divided into groups based on normal or abnormal CSF levels of Aβ1-42, t-tau, and p-tau181. SIENAX algorithms were employed for brain tissue volumes estimation and voxel-based morphometry (VBM) for mapping the differences in GM patterns. VBM revealed significant lower GM volumes in temporo-parietal, occipital, and prefrontal cortices for those subjects belonging to abnormal CSF t-tau and p-tau181 groups. No differences were found between groups according to CSF Aβ1-42 cut-offs. Patients with abnormal CSF p-tau181 showed lower cognitive performance compared to those with normal levels. Patients with abnormal levels of CSF tau (but not Aβ1-42) showed an Alzheimer's disease-like pattern for both GM distribution and cognitive profile, compared to those with normal levels. These results support the hypothesis that CSF t-tau or p-tau181 levels may be of direct value for the evaluation of disease severity.
dc.format.extent9 p.
dc.format.mimetypeapplication/pdf
dc.identifier.idgrec605108
dc.identifier.issn1387-2877
dc.identifier.urihttps://hdl.handle.net/2445/226185
dc.language.isoeng
dc.publisherIOS Press
dc.relation.isformatofReproducció del document publicat a: https://doi.org/10.3233/JAD-2012-111553
dc.relation.ispartofJournal of Alzheimer's Disease, 2012, vol. 29, num.4, p. 741-749
dc.relation.urihttps://doi.org/10.3233/JAD-2012-111553
dc.rights(c) Miralbell, J. et al., 2012
dc.rights.accessRightsinfo:eu-repo/semantics/openAccess
dc.subject.classificationMarcadors bioquímics
dc.subject.classificationTrastorns de la cognició
dc.subject.classificationCervell
dc.subject.otherBiochemical markers
dc.subject.otherCognition disorders
dc.subject.otherBrain
dc.titleGrey matter and cognitive patterns in cognitive impaired subjects using CSF biomarker cut-offs
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:eu-repo/semantics/publishedVersion

Fitxers

Paquet original

Mostrant 1 - 1 de 1
Carregant...
Miniatura
Nom:
149472.pdf
Mida:
224.56 KB
Format:
Adobe Portable Document Format